222 related articles for article (PubMed ID: 28377483)
1. Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3.
Weberpals JI; Lo B; Duciaume MM; Spaans JN; Clancy AA; Dimitroulakos J; Goss GD; Sekhon HS
Clin Cancer Res; 2017 Aug; 23(15):4501-4510. PubMed ID: 28377483
[No Abstract] [Full Text] [Related]
2. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
Zięba S; Kowalik A; Zalewski K; Rusetska N; Goryca K; Piaścik A; Misiek M; Bakuła-Zalewska E; Kopczyński J; Kowalski K; Radziszewski J; Bidziński M; Góźdź S; Kowalewska M
Gynecol Oncol; 2018 Sep; 150(3):552-561. PubMed ID: 29980281
[TBL] [Abstract][Full Text] [Related]
3. Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
Xing D; Fadare O
Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902
[TBL] [Abstract][Full Text] [Related]
4. The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy.
Clancy AA; Spaans JN; Weberpals JI
Ann Oncol; 2016 Sep; 27(9):1696-705. PubMed ID: 27329249
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus (HPV) and HPV 16-variant distribution in vulvar squamous cell carcinoma in Sweden.
Larsson GL; Helenius G; Andersson S; Elgh F; Sorbe B; Karlsson MG
Int J Gynecol Cancer; 2012 Oct; 22(8):1413-9. PubMed ID: 23013732
[TBL] [Abstract][Full Text] [Related]
6. Genomic characterization of vulvar squamous cell carcinoma.
Prieske K; Alawi M; Oliveira-Ferrer L; Jaeger A; Eylmann K; Burandt E; Schmalfeldt B; Joosse SA; Woelber L
Gynecol Oncol; 2020 Sep; 158(3):547-554. PubMed ID: 32591094
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome.
Tessier-Cloutier B; Pors J; Thompson E; Ho J; Prentice L; McConechy M; Aguirre-Hernandez R; Miller R; Leung S; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Hoang LN
Mod Pathol; 2021 Feb; 34(2):508-518. PubMed ID: 32792599
[TBL] [Abstract][Full Text] [Related]
8. Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node.
Lindell G; Näsman A; Jonsson C; Ehrsson RJ; Jacobsson H; Danielsson KG; Dalianis T; Källström BN; Larson B
Gynecol Oncol; 2010 May; 117(2):312-6. PubMed ID: 20138657
[TBL] [Abstract][Full Text] [Related]
9. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
[TBL] [Abstract][Full Text] [Related]
10. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.
Kortekaas KE; Santegoets SJ; Abdulrahman Z; van Ham VJ; van der Tol M; Ehsan I; van Doorn HC; Bosse T; van Poelgeest MIE; van der Burg SH
J Immunother Cancer; 2019 Sep; 7(1):236. PubMed ID: 31481117
[TBL] [Abstract][Full Text] [Related]
11. p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases.
Cheng AS; Karnezis AN; Jordan S; Singh N; McAlpine JN; Gilks CB
Int J Gynecol Pathol; 2016 Jul; 35(4):385-93. PubMed ID: 26630231
[TBL] [Abstract][Full Text] [Related]
12. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
Kashofer K; Regauer S
Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
[TBL] [Abstract][Full Text] [Related]
13. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
Sznurkowski JJ; Żawrocki A; Biernat W
BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
[TBL] [Abstract][Full Text] [Related]
14. CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma.
Trietsch MD; Spaans VM; ter Haar NT; Osse EM; Peters AA; Gaarenstroom KN; Fleuren GJ
Gynecol Oncol; 2014 Oct; 135(1):149-55. PubMed ID: 25072932
[TBL] [Abstract][Full Text] [Related]
15. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas.
Kim YT; Thomas NF; Kessis TD; Wilkinson EJ; Hedrick L; Cho KR
Hum Pathol; 1996 Apr; 27(4):389-95. PubMed ID: 8617483
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus and nonhuman papillomavirus pathways to vulvar squamous cell carcinoma: A review.
Nitecki R; Feltmate CM
Curr Probl Cancer; 2018 Sep; 42(5):476-485. PubMed ID: 30093165
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of FGFR3 in HPV-positive Tonsillar and Base of Tongue Cancer Is Correlated to Outcome.
Bersani C; Haeggblom L; Ursu RG; Giusca SE; Marklund L; Ramqvist T; Näsman A; Dalianis T
Anticancer Res; 2018 Aug; 38(8):4683-4690. PubMed ID: 30061236
[TBL] [Abstract][Full Text] [Related]
18. [Genetic aberrations and human papillomavirus status in vulvar squamous cell carcinomas].
Ouyang L; Zhang SL; Wang X
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):701-5. PubMed ID: 17199928
[TBL] [Abstract][Full Text] [Related]
19. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
[TBL] [Abstract][Full Text] [Related]
20. Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma.
Del Pino M; Rodriguez-Carunchio L; Ordi J
Histopathology; 2013 Jan; 62(1):161-75. PubMed ID: 23190170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
